Diapro MR Tablet 30 mg contains Gliclazide in a modified-release (MR) formulation. It is an oral antidiabetic medicine belonging to the sulfonylurea class, used for the management of type 2 diabetes mellitus in adults. The modified-release technology ensures gradual and consistent release of the active ingredient throughout the day, helping to maintain stable blood glucose levels with once-daily dosing. Diapro MR Tablet is prescribed when diet, exercise, and lifestyle changes alone are not sufficient to control blood sugar.
Gliclazide works by stimulating pancreatic beta cells to release insulin in response to elevated blood glucose levels. It also improves insulin sensitivity in peripheral tissues, enabling better utilization of glucose. The modified-release formulation provides a smooth and sustained insulin-stimulating effect, which helps reduce fluctuations in blood sugar levels and lowers the risk of sudden hypoglycemia compared to immediate-release formulations.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Diapro MR Tablet 30 mg is indicated for:
Treatment of type 2 diabetes mellitus in adults
Patients who do not achieve adequate glycemic control with diet and exercise alone
Use as monotherapy or in combination with other antidiabetic medicines such as metformin or insulin, under medical supervision
The dosage of Diapro MR Tablet should be individualized based on the patient’s blood glucose levels and overall response to therapy. It is usually taken once daily with breakfast. The tablet should be swallowed whole with water and should not be crushed or chewed, as this may affect the modified-release mechanism. Regular blood glucose monitoring is advised to ensure optimal control and safe dose adjustment.
Provides sustained blood glucose control over 24 hours
Convenient once-daily dosing improves patient compliance
Reduced risk of hypoglycemia when taken as prescribed
Helps lower both fasting and postprandial blood glucose levels
Supports prevention of long-term diabetes complications such as neuropathy, nephropathy, retinopathy, and cardiovascular disease
Diapro MR Tablet is generally well tolerated. Some patients may experience:
Hypoglycemia, especially if meals are skipped or doses are increased
Nausea, abdominal discomfort, or indigestion
Headache or dizziness
Mild weight gain in certain individuals
Severe hypoglycemia is uncommon but requires immediate medical attention if symptoms such as confusion, excessive sweating, or palpitations occur.
Use cautiously in elderly patients and in those with kidney or liver impairment
Alcohol intake may increase the risk of low blood sugar
Not recommended for patients with type 1 diabetes or diabetic ketoacidosis
Use during pregnancy and breastfeeding should be based on medical advice
Diapro MR Tablet may interact with other medicines such as beta-blockers, antifungal agents, anticoagulants, and certain antibiotics. Patients should inform their healthcare provider about all medications they are currently taking.
Store Diapro MR Tablet 30 mg in a cool, dry place away from direct sunlight. Keep out of reach of children.
Diapro MR Tablet 30 mg (Gliclazide) offers effective and sustained glycemic control for patients with type 2 diabetes mellitus. Its modified-release formulation supports once-daily dosing, improved compliance, and stable blood sugar management when combined with proper diet, exercise, and regular medical follow-up.
Login Or Registerto submit your questions to seller
No none asked to seller yet